Cargando…

Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20

Knee osteoarthritis is a chronic degenerative joint disease characterized by destruction of articular cartilage with resultant para-articular bone changes. It is a major cause of disability in older persons and is managed by surgical and nonsurgical interventions. Pharmacotherapy includes acetaminop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, David, Naidoo, Poobalan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376458/ https://www.ncbi.nlm.nih.gov/pubmed/30774462 http://dx.doi.org/10.2147/ORR.S174649

Ejemplares similares

Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2019)

Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years
por: Boutefnouchet, Tarek, et al.
Publicado: (2017)

Bilateral Hip Joint Hylan G-F 20 Granulomatous Synovitis due to Viscosupplementation Injections
por: Weinrauch, Patrick, et al.
Publicado: (2014)

Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20
por: Conduah, Augustine H, et al.
Publicado: (2009)

IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20
por: REZENDE, MÁRCIA UCHÔA DE, et al.
Publicado: (2020)

Total Knee Replacement Delayed With Hylan G-F 20 Use in Patients With Grade IV Osteoarthritis
por: Waddell, David D., et al.
Publicado: (2007)

Hylan G-F 20: Review of its Safety and Efficacy in the Management of Joint Pain in Osteoarthritis
por: Migliore, A., et al.
Publicado: (2010)

Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis
por: Heger, Robert, et al.
Publicado: (2016)

HYLAN G-F 20 VERSUS TRIAMCINOLONE IN THE TREATMENT OF PRIMARY SHOULDER OSTEOARTHRITIS. RANDOMIZED TRIAL
por: TORTATO, SIMONE, et al.
Publicado: (2022)

Efficacy and Safety of Hylan G-F 20 Versus Intra-Articular Corticosteroids in People with Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis
por: Chevalier, Xavier, et al.
Publicado: (2020)

Evaluation of Hylan G-F 20 Treatment with Opioid Prescriptions and Intraarticular Corticosteroid Injections in Patients with Osteoarthritis of the Knee Using a Claims Database
por: Langworthy, Michael J., et al.
Publicado: (2020)

Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees
por: Yanagisawa, Katsuaki, et al.
Publicado: (2016)

Viscosupplementation: Managed Care Issues for Osteoarthritis of the Knee
por: Arnold, William, et al.
Publicado: (2007)

One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: a systematic literature review and meta-analysis
por: De Lucia, Orazio, et al.
Publicado: (2020)

Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy
por: Huskin, J. P., et al.
Publicado: (2008)

Retrospective Comparative Analysis of Opioid Use and Intra-Articular Corticosteroid Injections Before and After Initial Treatment of Knee Osteoarthritis with Hylan G-F 20
por: Khangulov, Victor, et al.
Publicado: (2020)

Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis
Publicado: (2022)

Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis
por: Pereira, Tiago V, et al.
Publicado: (2022)

Viscosupplementation in the treatment of osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2012)

Intraarticular triamcinolone hexacetonide, stanozolol, Hylan G-F 20 and platelet concentrate in a naturally occurring canine osteoarthritis model
por: Alves, J. C., et al.
Publicado: (2021)

Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial
por: Wang, Yuanyuan, et al.
Publicado: (2011)

Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis
por: Pal, Sarvajeet, et al.
Publicado: (2014)

Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion
por: Bert, Jack, et al.
Publicado: (2018)

Intra-articular hyaluronan (Synvisc®, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised, placebo controlled trial
por: Zammit, Gerard V, et al.
Publicado: (2011)

VISCOSUPPLEMENTATION IN ANKLE OSTEOARTHRITIS: A SYSTEMATIC REVIEW
por: Faleiro, Thiago Batista, et al.
Publicado: (2016)

Worsen depression after viscosupplementation treatment for geriatric people with knee osteoarthritis?
por: Chen, Yu-Pin, et al.
Publicado: (2019)

Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
por: Chevalier, X, et al.
Publicado: (2009)

When is indicated viscosupplementation in hip osteoarthritis?
por: Francesco, Pogliacomi, et al.
Publicado: (2019)

Viscosupplementation for treating knee osteoarthrosis: review of the literature()
por: Ammar, Tiago Youssef, et al.
Publicado: (2015)

BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE KNEE (COBRAVI)
por: de Campos, Gustavo Constantino, et al.
Publicado: (2019)

EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2022)

Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial
por: Skrepnik, Nebojsa, et al.
Publicado: (2017)

Three Weekly Intra-Articular Injections of Hylan G-F 20 vs Arthrocentesis in Patients with Chronic Idiopathic Knee Osteoarthritis: A Multicenter, Evaluator- and Patient-Blinded, Randomized Controlled Trial
por: Huang, Yili, et al.
Publicado: (2023)

Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2019)

Viscosupplementation for Management of Knee Osteoarthritis from an Indian Perspective: An Expert Consensus Report
por: Tapasvi, Sachin, et al.
Publicado: (2019)

Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group
por: Conrozier, Thierry, et al.
Publicado: (2021)

Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action
por: Moreland, Larry W
Publicado: (2003)

VISCOSUPPLEMENTATION
por: de Rezende, Márcia Uchôa, et al.
Publicado: (2015)

Hyaluronic Acid (HA) Viscosupplementation on Synovial Fluid Inflammation in Knee Osteoarthritis: A Pilot Study
por: Vincent, Heather K, et al.
Publicado: (2013)

Intra-articular Injections With Either Triamcinolone Hexacetonide, Stanozolol, Hylan G-F 20, or a Platelet Concentrate Improve Clinical Signs in Police Working Dogs With Bilateral Hip Osteoarthritis
por: Alves, João C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j214f1taadnk7cd6dqc404andp